MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
A Phase 1b/2, open-label, randomized study to evaluate MEDI-573 in combination with standard of care in adult subjects with unresectable or metastatic hepatocellular carcinoma (HCC).
Epistemonikos ID: 06a110a4ac91e549d34e7c082845612c52339494
First added on: May 10, 2024